Increased malignant microcalcifications after neoadjuvant chemotherapy in advanced breast cancer

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

In patients with advanced breast cancer, most new calcifications detected on a mammogram after neoadjuvant chemotherapy are benign dystrophic calcifications, but this is not always observed. We present a patient with advanced breast cancer who had paradoxically increased malignant microcalcifications concomitant with primary tumor regression after undergoing neoadjuvant chemotherapy. After the neoadjuvant chemotherapy, the follow-up mammogram revealed that local, fine pleomorphic microcalcifications had markedly increased. Pathologically, these calcifications were ductal carcinoma in situ. We concluded that, in patients with breast cancer undergoing neoadjuvant chemotherapy, newly developed microcalcifications on follow-up mammograms should be carefully evaluated, and any suspicious malignant microcalcifications should be included in surgical excision planning.

Cite

CITATION STYLE

APA

Shin, G. W., Park, Y. M., Yoon, H. K., Jung, S. J., Kim, T. H., Lee, A., & Lee, S. M. (2016). Increased malignant microcalcifications after neoadjuvant chemotherapy in advanced breast cancer. Journal of Breast Cancer, 19(4), 459–464. https://doi.org/10.4048/jbc.2016.19.4.459

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free